|
5/2010
|
PHRM 513 Medical Pharmacology
Gave lectures in Cancer Pharmacology
|
|
4/2010 - 6/2010
|
IBGS 513 Cellular Mechanisms & Integrated Systems
|
|
1/2010 - 3/2010
|
IBGS 512 Cellular Mechanisms & Integrated Systems
|
|
8/2009 - 12/2009
|
IBGS 511 Cellular Mechanisms & Integrated Systems
|
|
3/2009 - 6/2009
|
IBGS 513 Cellular Mechanisms and Integrated Systems
|
|
3/2009 - 5/2009
|
PHRM 513 Medical Pharmacology
|
|
1/2007 - 3/2007
|
IBGS 512-Cellular Mechanisms and Integrated Systems
This course was designed to enable students to develop an integrated understanding of the experimental foundations and current state of biomedical science using lectures, literature-based discussions and problem-solving approaches. I specifically gave a two hour lecture regarding current approaches to drug discovery and development of cancer chemotherapeutic agents.
|
|
1/2007 - 3/2007
|
RXPS 715 Medicinal Chemistry V
This is a foundation course offered to pharmacy students which presented the chemistry related to drug activity including pharmacology, toxicology, absorption, distribution, metabolism, excretion, mechanism of action, drug-drug interactions, dosage form formulation(s), stability, cost and use. I specifically taught lectures related to Cancer Chemotherapeutics. Altogether 11 one hour lectures were given regarding this topic.
|
|
9/2006 - 12/2006
|
PHRM 511 Medical Pharmacology
This course is designed to expose students to the general principles in pharmacology including pharmacodynamic and pharmacokinetic indices. I specifically gave a two hour lecture related to Cancer Pharmacology.
|
|
5/2005
|
RXPS 613 Medicinal Chemistry III
This is the third portion of a six quarter series medicinal chemistry course. I contributed three lectures to this course discussing the medicinal chemistry of agents that affect ion channels.
|
|
4/2005
|
RXPS 716 Medicinal Chemistry VI
This course was the final portion of a six quarter series medicinal chemistry course. I gave three lectures which completed lectures of the previous quarter discussing the medicinal chemistry of anticancer agents. In addition, I helped supervise workshops designed to emphasize principles discussed during lectures.
|
|
2/2005 - 3/2005
|
RXPS 715 Medicinal Chemistry V
This fifth portion of a six quarter series course primarily discussed the medicinal chemistry of chemotherapeutic agents. I contributed 8 lectures on the medicinal chemistry of cancer chemotherapeutic agents. In addition, I supervised workshops which reinforced principles taught during lectures.
|
|
1/2005 - 2/2005
|
RXPS 612 Medicinal Chemistry II
This course discussed principles related to the molecular mechanism of drug action and is the second portion of a six quarter sequence medicinal chemistry course. I contributed 8 lectures to this team taught course in addition to workshops that aided in reinforcing concepts taught during lectures. The lectures I was directly responsible for discussed the medicinal chemistry of agents that affect dopaminergic, adrenergic and cholinergic neurotransmission.
|
|
9/2004
|
Pharmacology/Pharmacokinetics of Antimigraine agents: 5HT agonists, ergot alkaloids
This one hour lecture was designed to introduce students to the pharmacology and pharmacokinetics of agents used in the treatment of migraine headaches. The etiology of migraines was also discussed. This lecture was given as a portion of a course, RXTH 771: Neurological Disorders (IPDMX).
|